Cargando…

Assessment of Renal Function in Head and Neck Cancer Patients Treated with Cisplatin: Different Biomarkers and Acute Kidney Injury Classifications

Cisplatin is associated with dose-limiting nephrotoxicity, and the timely detection of acute kidney injury (AKI) can affect morbimortality. Therefore, this study aimed to investigate the tools for monitoring renal function in AKI. This was a retrospective, cohort study. Cisplatin-treated patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Godoy Torso, Nadine, Visacri, Marília Berlofa, Quintanilha, Julia Coelho França, Cursino, Maria Aparecida, Pincinato, Eder de Carvalho, Moriel, Patricia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820437/ https://www.ncbi.nlm.nih.gov/pubmed/36613585 http://dx.doi.org/10.3390/ijms24010141

Ejemplares similares

Data Normalization of Urine miRNA Profiling from Head and Neck Cancer Patients Treated with Cisplatin
por: Torso, Nadine de Godoy, et al.
Publicado: (2023)

Adverse drug reactions and kinetics of cisplatin excretion in urine of patients undergoing cisplatin chemotherapy and radiotherapy for head and neck cancer: a prospective study
por: Visacri, Marília Berlofa, et al.
Publicado: (2017)

Contribution of MicroRNAs in Chemoresistance to Cisplatin in the Top Five Deadliest Cancer: An Updated Review
por: Loren, Pía, et al.
Publicado: (2022)

Leukocytoclastic vasculitis complicating cisplatin + radiation treatment for laryngeal cancer: a case report
por: Quintanilha, Júlia Coelho França, et al.
Publicado: (2017)

MiR-3168, miR-6125, and miR-4718 as potential predictors of cisplatin-induced nephrotoxicity in patients with head and neck cancer
por: Quintanilha, Julia C. F., et al.
Publicado: (2021)

Dysregulated MicroRNAs as Biomarkers or Therapeutic Targets in Cisplatin-Induced Nephrotoxicity: A Systematic Review
por: de Godoy Torso, Nadine, et al.
Publicado: (2021)

Polymorphisms in DNA mismatch repair pathway genes predict toxicity and response to cisplatin chemoradiation in head and neck squamous cell carcinoma patients
por: Nogueira, Guilherme Augusto Silva, et al.
Publicado: (2018)

Do Genetic Polymorphisms Modulate Response Rate and Toxicity of Cisplatin Associated With Radiotherapy in Laryngeal Squamous Cell Carcinoma?: A Case Report
por: Lopes-Aguiar, Leisa, et al.
Publicado: (2015)

XPD c.934G>A polymorphism of nucleotide excision repair pathway in outcome of head and neck squamous cell carcinoma patients treated with cisplatin chemoradiation
por: Lopes-Aguiar, Leisa, et al.
Publicado: (2016)

Evaluation of the quality of life of patients before treatment of squamous cell carcinoma of the head and neck by means of chemoradiotherapy
por: Visacri, Marília Berlofa, et al.
Publicado: (2015)

Role of miRNAs as biomarkers of COVID-19: a scoping review of the status and future directions for research in this field
por: Visacri, Marília B, et al.
Publicado: (2021)

GSTM1, GSTT1 and GSTP1 Ile105Val polymorphisms in outcomes of head and neck squamous cell carcinoma patients treated with cisplatin chemoradiation
por: Pincinato, Eder C., et al.
Publicado: (2019)

Cost analysis of pharmaceutical care provided to HIV-infected patients: an ambispective controlled study
por: Carnevale, Renata Cavalcanti, et al.
Publicado: (2015)

High 15-F(2t)-Isoprostane Levels in Patients with a Previous History of Nonmelanoma Skin Cancer: The Effects of Supplementary Antioxidant Therapy
por: Freitas, Betânia de Jesus e Silva de Almendra, et al.
Publicado: (2015)

Role of pharmacist during the COVID-19 pandemic: A scoping review
por: Visacri, Marília Berlofa, et al.
Publicado: (2021)

Impact of pharmacist interventions on drug-related problems and laboratory markers in outpatients with human immunodeficiency virus infection
por: Molino, Caroline de Godoi Rezende Costa, et al.
Publicado: (2014)

Adverse Drug Reactions and quality deviations monitored by spontaneous reports
por: Visacri, Marília Berlofa, et al.
Publicado: (2015)

Can acetylcysteine ameliorate cisplatin‐induced toxicities and oxidative stress without decreasing antitumor efficacy? A randomized, double‐blind, placebo‐controlled trial involving patients with head and neck cancer
por: Visacri, Marília B., et al.
Publicado: (2019)

Differentially expressed plasmatic microRNAs in Brazilian patients with Coronavirus disease 2019 (COVID-19): preliminary results
por: Nicoletti, Aline de Souza, et al.
Publicado: (2022)

Influence of Soy Lecithin Administration on Hypercholesterolemia
por: Mourad, Amouni Mohamed, et al.
Publicado: (2010)

Role of pharmacist in the management of Hansen's Disease: A scoping review
por: de Oliveira Duarte, Elza Cristina, et al.
Publicado: (2023)

Potential Drug Interactions and Drug Risk during Pregnancy and Breastfeeding: An Observational Study in a Women's Health Intensive Care Unit
por: Ferracini, Amanda Canato, et al.
Publicado: (2017)

Chemoradiotherapy With Generic Cisplatin Formulations for Head and Neck Cancers
por: Shimada, Rie, et al.
Publicado: (2018)

Feasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma
por: Jacinto, Alexandre Arthur, et al.
Publicado: (2018)

Multi-kinase inhibitors and cisplatin for head and neck cancer treatment in vitro
por: Brands, Roman C., et al.
Publicado: (2019)

Comparison of vinorelbine with cisplatin in concomitant chemoradiotherapy in head and neck carcinoma
por: Devleena,, et al.
Publicado: (2010)

Head and neck irradiation modulates pharmacokinetics of 5-fluorouracil and cisplatin
por: Hsieh, Chen-Hsi, et al.
Publicado: (2013)

Prognostic Factors for the Therapeutic Performance of Cisplatin in Head and Neck Malignancies
por: Jungbauer, Frederic, et al.
Publicado: (2022)

Decitabine Rescues Cisplatin Resistance in Head and Neck Squamous Cell Carcinoma
por: Viet, Chi T., et al.
Publicado: (2014)

Effect of sorafenib on cisplatin-based chemoradiation in head and neck cancer cells
por: Möckelmann, Nikolaus, et al.
Publicado: (2016)

Identification of hub genes involved in cisplatin resistance in head and neck cancer
por: Chaudhary, Raushan Kumar, et al.
Publicado: (2023)

MicroRNAs as the pivotal regulators of cisplatin resistance in head and neck cancers
por: Tolue Ghasaban, Faezeh, et al.
Publicado: (2023)

Valproic acid combined with cisplatin-based chemoradiation in locally advanced head and neck squamous cell carcinoma patients and associated biomarkers
por: Mak, Milena Perez, et al.
Publicado: (2020)

Renal protective effect of a hydration supplemented with magnesium in patients receiving cisplatin for head and neck cancer
por: Kimura, Takahiro, et al.
Publicado: (2018)

Metoclopramide enhances the effect of cisplatin on xenografted squamous cell carcinoma of the head and neck.
por: KjellÃ©n, E., et al.
Publicado: (1989)

Improving Therapeutic Ratio in Head and Neck Cancer with Adjuvant and Cisplatin-Based Treatments
por: Marcu, Loredana G.
Publicado: (2013)

FGFR signaling regulates resistance of head and neck cancer stem cells to cisplatin
por: McDermott, Sarah C., et al.
Publicado: (2018)

The Nephroprotective Effect of Mannitol in Head and Neck Cancer Patients Receiving Cisplatin Therapy
por: Hägerström, Erik, et al.
Publicado: (2019)

Mechanisms of Cisplatin Resistance in HPV Negative Head and Neck Squamous Cell Carcinomas
por: Griso, Ana Belén, et al.
Publicado: (2022)

Chemoradiation with Cisplatin vs. Carboplatin for Squamous Cell Carcinoma of the Head and Neck (SCCHN)
por: Rades, Dirk, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_knhpimarg4et7gm4jpfpouahv8